
Early Development and The Dose Selection in the Immune-oncology
The Effective Statistician - in association with PSI
00:00
Intro
The chapter features a guest expert in statistics and biostatistics, focusing on their experience in clinical research and drug development. The discussion highlights the complexities of early development and dose selection in the field of immune-oncology.
Transcript
Play full episode